BIOVECTRA is honored with 2025 CDMO Leadership Award for biologics

BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 Outsourced Pharma CDMO Leadership Award in the category of biologics.

Study assesses duration of protection offered by smallpox infection and possible cross-reaction with Mpox virus

More than 43 years ago, many Chinese residents were vaccinated with the vaccinia virus Tiantan strain (VTT) to protect them from smallpox infection.

September 19, 2023

Chiesi’s new licensing deal with Haisco; Oxurion to file for bankruptcy; Hong Kong CDMO raises $210M

Chiesi, Haisco to develop respiratory treatment outside of China: The companies said Monday that they plan to work together to develop, manufacture and potentially commercialize

November 21, 2023

Biotest AG opens 13th plasma collection center in Germany – Biotech Investments

EQS-News: Biotest AG / Key word(s): Miscellaneous Biotest AG opens 13th plasma collection center in Germany 05.09.2024 / 09:00 CET/CEST The issuer is solely responsible

September 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.